These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11768273)

  • 1. Effect of three nonpeptide cholecystokinin antagonists on human isolated gallbladder.
    Maselli MA; Piepoli AL; Pezzolla F; Guerra V; Caruso ML; Mennuni L; Lorusso D; Makovec F
    Dig Dis Sci; 2001 Dec; 46(12):2773-8. PubMed ID: 11768273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proglumide antagonizes the stimulation of rabbit gallbladder by cholecystokinin.
    Kaplita PV; Roebuck BD
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):271-6. PubMed ID: 6476983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK1 receptor antagonist, dexloxiglumide: effects on human isolated gallbladder. Potential clinical applications.
    Maselli MA; Mennuni L
    Minerva Gastroenterol Dietol; 2003 Sep; 49(3):211-6. PubMed ID: 16484960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a novel CCK-antagonist (lorglumide) on human and guinea pig gallbladder strips: a tensiometric study.
    Portincasa P; Brandonisio R; Di Ciaula A; Maggi V; Chiloiro M; Palasciano G
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):567-73. PubMed ID: 2257123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.
    Makovec F; Chistè R; Bani M; Pacini MA; Setnikar I; Rovati LA
    Arzneimittelforschung; 1985; 35(7):1048-51. PubMed ID: 4052139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK.
    Makovec F; Bani M; Cereda R; Chistè R; Pacini MA; Revel L; Rovati LC
    Pharmacol Res Commun; 1987 Jan; 19(1):41-51. PubMed ID: 3575382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lorglumide and atropine on MgSO(4)-induced gallbladder emptying in conscious dogs.
    Sterczer A; Szénási G; Vörös K; Pap A
    Res Vet Sci; 2000 Oct; 69(2):129-33. PubMed ID: 11020363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
    Morton MF; Barrett TD; Yan W; Freedman JM; Lagaud G; Prendergast CE; Moreno V; Pyati J; Figueroa K; Li L; Wu X; Rizzolio M; Breitenbucher JG; McClure K; Shankley NP
    J Pharmacol Exp Ther; 2007 Nov; 323(2):562-9. PubMed ID: 17684117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of loxiglumide (CR 1505) on CCK-induced contractions and 3H-acetylcholine release from guinea-pig gallbladder.
    Rakovska A; Sgaragli G; Mantovani P; Valoti M; Milenov K
    Neuropeptides; 1993 Nov; 25(5):271-6. PubMed ID: 8115030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gastrin-releasing peptide (GRP) on guinea pig gallbladder contraction in vitro.
    Liu F; Naruse S; Ozaki T; Sazi T; Kondo T; Toda Y
    J Gastroenterol; 1995 Dec; 30(6):764-7. PubMed ID: 8963395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M; Stamford IF; Bennett A
    Br J Pharmacol; 1991 Feb; 102(2):391-5. PubMed ID: 2015421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a cholecystokinin antagonist, proglumide, on cholecystokinin-8-induced gallbladder contraction in conscious dogs.
    Fujimura M; Sakamoto T; Lluis F; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):94-100. PubMed ID: 1307918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    Varga G; Kordás K; Burghardt B; Gacsályi I; Szénási G
    Eur J Pharmacol; 1999 Feb; 367(2-3):315-23. PubMed ID: 10079007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.